Results 1 to 10 of about 359,045 (205)

A Nonrandomized Phase 2 Trial of EG-Mirotin, a Novel, First-in-Class, Subcutaneously Deliverable Peptide Drug for Nonproliferative Diabetic Retinopathy [PDF]

Medicina (Lithuania), 2023
Background and objectives: EG-Mirotin (active ingredient EGT022) targets nonproliferative diabetic retinopathy (NPDR), the early stage of retinopathy. EG-Mirotin reverses capillary damage before NPDR progresses to an irreversible stage. EG-Mirotin safety
Jeongyoon Lee, Seunghoon Yoo, H Christian   +2 more
exaly   +4 more sources

Diabetic Retinopathy Severity and Heart Failure Outcomes in Type 2 Diabetes Mellitus [PDF]

Journal of Diabetes
Background The precise link between diabetic retinopathy and incident heart failure remains unclear, largely limited by a lack of echocardiographic data.
Feng‐Ching Shen, Pei‐Kang Liu, Yi‐Chen Huang, Teng‐Hui Huang, Ming‐Yen Lin, Yi‐Hsueh Liu, Tien‐Chi Huang, Mei‐Chuan Kuo, Yi‐Wen Chiu, Shang‐Jyh Hwang, Yi‐Ting Lin, Ping‐Hsun Wu   +11 more
doaj   +3 more sources

Effects of intravitreal bevacizumab injection on the clinical manifestations of nonproliferative diabetic retinopathy in patients with macular edema: a systematic review [PDF]

Reviews in Clinical Medicine, 2016
Introduction: Bevacizumab (Avastin) is considered as an effective strategy in the treatment of various ocular diseases. As a vascular endothelial growth factor (VEGF) inhibitor, Avastin is used to control macular edema in patients with nonproliferative ...
Touka Banaee, Naser Shoeibi, Hosein Ghavam Saeedi   +2 more
doaj   +2 more sources

Deep Capillary Nonperfusion on OCT Angiography Predicts Complications in Eyes with Referable Nonproliferative Diabetic Retinopathy [PDF]

Ophthalmology Retina, 2023
Janice Ong, Hisashi Fukuyama, Amani Fawzi   +2 more
exaly   +2 more sources

Progression of Capillary Hypoperfusion in Advanced Stages of Nonproliferative Diabetic Retinopathy: 6-month Analysis of RICHARD Study [PDF]

Ophthalmology Science
Inés P Marques, José Cunha-Vaz, Luís Mendes   +2 more
exaly   +2 more sources

Evaluation of Intravitreal Aflibercept for the Treatment of Severe Nonproliferative Diabetic Retinopathy: Results From the PANORAMA Randomized Clinical Trial

JAMA Ophthalmology, 2021
Karen Wendy Chu, Charles C Wykoff, Robert Vitti   +2 more
exaly   +2 more sources

A broad study of machine learning and deep learning techniques for diabetic retinopathy based on feature extraction, detection and classification

Measurement: Sensors, 2023
Diabetic Retinopathy (DR) is a micro vasculardisorder that affects the eyes and is a long term effectofDiabetesmellitus. The likelihood to develop diabetic retinopathy is directly proportional to the age and duration of the diabetes, as well as increase ...
Krishnan Sangeetha, K. Valarmathi, T. Kalaichelvi, S. Subburaj   +3 more
doaj   +1 more source

Matrix Metalloproteinases in Predicting Nonproliferative Diabetic Retinopathy in Old Age

Oftalʹmologiâ, 2023
The development of diabetic retinopathy is associated with matrix metalloproteinases, but they are rarely used to predict this pathology. The purpose of the study is to predict the development of nonproliferative diabetic retinopathy in old age based on ...
O. L. Fabikantov, I. V. Lev, N. M. Agarkov, R. E. Osmanov   +3 more
doaj   +1 more source

Evaluation of retrobulbar circulation in diabetic patients using color Doppler imaging

Journal of Clinical Ophthalmology and Research, 2023
Background: Diabetic retinopathy (DR) is a microvasculature disorder of the retina. Color Doppler imaging is a new method that allows simultaneous two-dimensional anatomical and Doppler evaluation of hemodynamic characteristics of the retinal artery. Aim:
Amit Shankhwar, Neetu Shankhwar, Suraj Mathur, Anurag Ananthan, Pallavi Chaudhary   +4 more
doaj   +1 more source

Influence of diabetes mellitus on corneal thickness [PDF]

Srpski Arhiv za Celokupno Lekarstvo, 2014
Introduction. Ultrastructural changes in corneas of patients with diabetes mellitus have been previously described. Objective. The aim of this study was to compare central corneal thickness (CDR) values in diabetic patients without retinopathy ...
Senćanić Ivan, Stamenković Miroslav, Jovanović Vesna, Babović Siniša, Jakšić Vesna, Marković Petar   +5 more
doaj   +1 more source